The pace of big funding rounds continued to hold up at brisk levels this past week, led by a $1.4 billion financing for ...

Eli Lilly and Nvidia, two primary drivers of the recent stock market rally, are deepening their alliance to connect silicon ...

Nvidia and Eli Lilly's AI tie-up shows drug discovery emerging as a new ETF growth theme across semiconductors and health ...

Nvidia is turning its AI firepower toward the hardest problems in medicine, striking multibillion-dollar alliances with ...

Nvidia and Eli Lilly are teaming up on a $1 billion AI-powered lab to accelerate drug discovery, combining robotics, molecular modeling and automated research workflows.

An inconsistent boom-and-bust cycle funding environment for early-stage biotech innovations and burdensome regulation ...

What happens when machines don’t just help humans, but surpass them at the most delicate, high-stakes task imaginable? Elon ...

The Global Agtech and Advanced Food Technologies Market Report 2026-2036 reveals promising growth opportunities in vertical farming, smart farming, and alternative proteins, driven by population ...

Medtronic has announced plans to double the footprint of its London office, focused on developing artificial intelligence and digital technologies such as robotic surgery, both in its physical size ...

The artificial intelligence sector continues to attract substantial investment across various stages of funding, from seed to Series B, despite some broader market uncertainties. The past week has ...

Gilead Sciences, Inc. (NASDAQ:GILD), headquartered in Foster City, California, continues to lead in antiviral and oncology therapies while advancing next-generation biologics through AI integration.

NantWorks, LLC, and ImmunityBio, Inc. (NASDAQ: IBRX), today announced the inaugural U.S.-Saudi Biotech Alliance Summit, to be ...